Viewing Study NCT06521567


Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2026-01-24 @ 3:44 AM
Study NCT ID: NCT06521567
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-12
First Post: 2024-07-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module